BioCentury | Apr 22, 2019
Distillery Therapeutics

Combined inhibition of EGFR and RAF1 for mutant-KRAS, mutant TP53-driven PDAC

...2019 doi:10.1016/j.ccell.2019.03.002 CONTACT: Carmen Guerra, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Ramon and Cajal Institute...
...Madrid, Spain email: mcguerra@cnio.es CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Sandi Wong Ramon and Cajal Institute...
BioCentury | Sep 20, 2017
Distillery Therapeutics

Autoimmune disease

...published online Aug. 30, 2017 doi:10.1523/JNEUROSCI.2900-16.2017 CONTACT: Carmen Guaza, Cajal Institute, Madrid, Spain email: miriammecha@cajal.csic.es Michael Leviten Cajal Institute Monoglyceride...
BioCentury | Jun 17, 2013
Company News

Aphios, VivaCell deal

...U.S. and Europe. The compounds were discovered by phytocannabinoids company VivaCell in collaboration with the Cajal Institute...
BioCentury | Mar 22, 2012
Targets & Mechanisms

Gleevec for pain

...experience the added benefit of reduced morphine tolerance. Javier Garzón, head of neuropharmacology at the Cajal Institute...
...Martz, L. SciBX 5 (12); doi:10.1038/scibx.2012.300 Published online March 22, 2012 Companies and Institutions Mentioned Cajal Institute...
BioCentury | Sep 4, 2008
Distillery Therapeutics

This Week in Therapeutics

...al. Proc. Natl. Acad. Sci. USA; published online Aug. 18, 2008; doi:10.1073/pnas.0803174105 Contact: Alfredo Martnez, Cajal Institute...
BioCentury | Nov 11, 2002
Company News

Cajal Institute other research news

...in markedly reduced brain amyloid-beta burden, which is linked to the pathogenesis of Alzheimer's disease. Cajal Institute...
BioCentury | Feb 9, 1998
Company News

Cajal Institute other research news

...in The Proceedings of the National Academy of Sciences. No treatment exists for cerebellar ataxia. Cajal Institute...
Items per page:
1 - 7 of 7
BioCentury | Apr 22, 2019
Distillery Therapeutics

Combined inhibition of EGFR and RAF1 for mutant-KRAS, mutant TP53-driven PDAC

...2019 doi:10.1016/j.ccell.2019.03.002 CONTACT: Carmen Guerra, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Ramon and Cajal Institute...
...Madrid, Spain email: mcguerra@cnio.es CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Sandi Wong Ramon and Cajal Institute...
BioCentury | Sep 20, 2017
Distillery Therapeutics

Autoimmune disease

...published online Aug. 30, 2017 doi:10.1523/JNEUROSCI.2900-16.2017 CONTACT: Carmen Guaza, Cajal Institute, Madrid, Spain email: miriammecha@cajal.csic.es Michael Leviten Cajal Institute Monoglyceride...
BioCentury | Jun 17, 2013
Company News

Aphios, VivaCell deal

...U.S. and Europe. The compounds were discovered by phytocannabinoids company VivaCell in collaboration with the Cajal Institute...
BioCentury | Mar 22, 2012
Targets & Mechanisms

Gleevec for pain

...experience the added benefit of reduced morphine tolerance. Javier Garzón, head of neuropharmacology at the Cajal Institute...
...Martz, L. SciBX 5 (12); doi:10.1038/scibx.2012.300 Published online March 22, 2012 Companies and Institutions Mentioned Cajal Institute...
BioCentury | Sep 4, 2008
Distillery Therapeutics

This Week in Therapeutics

...al. Proc. Natl. Acad. Sci. USA; published online Aug. 18, 2008; doi:10.1073/pnas.0803174105 Contact: Alfredo Martnez, Cajal Institute...
BioCentury | Nov 11, 2002
Company News

Cajal Institute other research news

...in markedly reduced brain amyloid-beta burden, which is linked to the pathogenesis of Alzheimer's disease. Cajal Institute...
BioCentury | Feb 9, 1998
Company News

Cajal Institute other research news

...in The Proceedings of the National Academy of Sciences. No treatment exists for cerebellar ataxia. Cajal Institute...
Items per page:
1 - 7 of 7